CONGRESS PROGRAMME
Thursday, 28 April
09.00
Opening Session
Symposium
Symposium II
EARLY
CANCER
DETECTION
TUMOUR
IMMUNOLOGY
Chairs:
Dias
Pereira,Demengeot
Carla Oliveira
Chairs: António
José Dinis,
Jocelyne
Friday, 29 April
SymposiumIII
Symposium IV
CANCER
GENES:
WHAT DID
LEARN FROM
THEM?MODEL
SIGNALING
PATHWAYS:
THEWE
ANDROGEN
RECEPTOR
Chair: Sergio Dias, João Nuno Moreira
Chairs: Carmen Jerónimo, Nuno Sousa
09.30
Wytske van Weerden . Netherlands
The continued role of AR in castration-resistant prostate cancer.
09.30
Bruno Silva Santos . Portugal
Gamma-delta T lymphocytes in the tumour environment: from
oncoimmunology to adoptive cell immunotherapy.
10.00
Jolanda de Vries . Netherlands
10.00
Tiffany Traina . United States
The role of the AR in advanced breast cancer.
10.30
2 selected oral presentations
11.00
Coffee-break
Harnessing adaptive immune responses in hereditary cancer.
10.30
11.00
2 selected oral presentations
Coffee-break
Symposium
Symposium IIII
NEW
RESEARCH APPROACHES
FROM ASPIC –ASEICA
IMMUNOMODULATION
OF CANCER
Chairs:
Carrato
(Spain)
Leonor David (Portugal)
Chairs: Alfredo
Bruno Silva
Santos,
Júlioand
Oliveira
11.30
Frederick Arce Vargas . United Kingdom
Symposium V
CELL AND TUMOUR BIOLOGY
Chairs: Luís Costa, Fátima Baltazar
11.30
Gunther Boysen . United Kingdom
Molecular features of SPOP mutant/ CHD1 deleted prostate cancer.
12.00
Joan Seoane . Spain
Tackling intratumour heterogeneity in brain tumors.
Targeting immune regulation in the tumour site.
12.00
12.30
2 selected oral presentations
13.00
Lunch
Jeffrey Weber . United States
Novel checkpoint blockade combinations and biomarkers.
12.30
2 selected oral presentations
13.00
Lunch
14.00
Poster Parallel Sessions
Symposium III
RADIATION BIOLOGY AND RADIOTHERAPY
Chairs: Luísa Carvalho, Pedro Almeida
MECHANISMS
AND IMPLICATIONS OF TUMOUR
PLENARY LECTURES
HETEROGENEITY
Chairs: Manuel Sobrinho Simões, Nuno Miranda,
Jorge Soares, Carlos Camps
14.00
14.45
16.00
Rolf Lewensohn . Sweden
(title to be announced)
16.30
Marie Dutreix . France
Focus on the combination of DNA repair inhibitors with radiotherapy.
Alberto Cambrosio . Canada
ASPIC lecture
Mapping the development of Portuguese clinical research in
oncology.
Luis Paz Ares . Spain
ASEICA lecture
Lung cancer precision treatment.
15.30
Richard Marais . United Kingdom
17.00
2 selected oral presentations
EACR lecture
RAS and RAF signalling in melanoma: from basic biology to
clinical responses.
17.30
Coffee-break
16.15
18.00
19:00
ASPIC General Assembly
20.00
Congress Dinner
Awards
Closing Session